PB

Pawan Bhagwan Das Agrawal

Active Director Cfo DIN 08863625
DIN 08863625 First appointment Sep 2020 Primary industry FMCG
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 5 historical roles
Total affiliations 7 Since Sep 2020
Shareholding value •••• Premium profile

About Pawan Bhagwan Das Agrawal

Data last updated:

Pawan Bhagwan Das Agrawal is a Cfo at Marico Limited (since 2020) and Director at Duroflex Limited (since 2025). The companies operate in FMCG, Consumer Goods and Business Outsourcing. The 2 current companies with reported revenue have a combined latest revenue of ₹14,968 Cr; the largest is Marico Limited at ₹13,815 Cr (FY 2026). Earlier, Pawan Bhagwan Das Agrawal was a Director at Juizo Advisory Private Limited (2023–2024) and Director at Satiya Nutraceuticals Private Limited (2023–2024) and 3 more.

DIN 08863625
Primary Designation Cfo
Industry FMCG
First Appointment 10 Sep 2020
Oldest Company Age 45 yrs
Largest company Marico Limited · ₹13,815 Cr (FY 2026)
Combined revenue ₹14,968 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Marico Limited L15140MH1988PLC049208
Cfo10 Sep 20201988₹13,815 Cr (FY 2026)Active
Duroflex Limited U36104KL1981PLC003447
Director09 Sep 20251981₹1,153 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Juizo Advisory Private Limited U93000MH2019PTC327385
Director26 Jul 20232019₹58.05 Cr (FY 2025)Active
Director26 Jul 20232020₹866 Cr (FY 2026)Active
Apcos Naturals Private Limited U74999PB2018PTC048652
Director21 Jul 20212018₹98.93 Cr (FY 2025)Under Liquidation
Director23 May 20222013₹165 Cr (FY 2025)Active
Marico Consumer Care Limited U24233MH2012PLC229972
Director10 Sep 20202012₹6.77 Cr (FY 2020)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Pawan Bhagwan Das Agrawal

Directorship timeline

Open interactive timeline →
Marico Limited
Marico Consumer Care Limited
Duroflex Limited
Juizo Advisory Private Limited
Premium access

Shareholding and investment profile for Pawan Bhagwan Das Agrawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pawan Bhagwan Das Agrawal

Pawan Bhagwan Das Agrawal currently holds 2 directorships: Marico Limited (Cfo, since 10 Sep 2020, revenue ₹13,815 Cr (FY 2026)); Duroflex Limited (Director, since 09 Sep 2025, revenue ₹1,153 Cr (FY 2025)).

Pawan Bhagwan Das Agrawal was first appointed on 10 Sep 2020 as Cfo at Marico Limited. The most recent appointment on record is 09 Sep 2025 at Duroflex Limited.

The 2 current companies of Pawan Bhagwan Das Agrawal that report revenue have a combined latest revenue of ₹14,968 Cr: Marico Limited ₹13,815 Cr (FY 2026); Duroflex Limited ₹1,153 Cr (FY 2025).

Pawan Bhagwan Das Agrawal held 5 earlier board appointments: Juizo Advisory Private Limited (Director, 26 Jul 2023 to 14 Mar 2024); Satiya Nutraceuticals Private Limited (Director, 26 Jul 2023 to 14 Mar 2024); Apcos Naturals Private Limited (Director, 21 Jul 2021 to 22 Mar 2024); Hw Wellness Solutions Private Limited (Director, 23 May 2022 to 18 Mar 2024); Marico Consumer Care Limited (Director, from 10 Sep 2020).

The current boards of Pawan Bhagwan Das Agrawal's companies include Ananth Sankaranarayanan (Marico Limited), Apurva Purohit (Marico Limited), Bhaskar Bhat (Marico Limited), Girish Srikrishna Paranjpe (Marico Limited), Harsh Charandas Mariwala (Marico Limited), Mandyam Anandampillai Vinay (Marico Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available